Nemaura Medical
(OTC) NMRD
Nemaura Medical Financials at a Glance
Market Cap
$4.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
-$1.55M
Net Income (TTM)
-$6.30M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-2623.07 (Low)
Dividend
$0.00
Beta (Volatility)
-2623.07 (Low)
Price
$0.00
Volume
1,820
Open
$0.00
Price
$0.00
Volume
1,820
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.05
Estimated Earnings Date
Aug 10, 2026
Dividend
$0.00
Beta (Volatility)
-2623.07 (Low)
Price
$0.00
Volume
1,820
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.05
Estimated Earnings Date
Aug 10, 2026
NMRD News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Nemaura Medical
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
38
CEO
Dewan Fazlul Hoque Chowdhury, PhD
Website
www.nemauramedical.comHeadquarters
New York City, NY 10019, US
NMRD Financials
Key Financial Metrics (TTM)
Gross Margin
-1916.30%
Operating Margin
-12454.23%
Net Income Margin
-18358.00%
Return on Equity
249.27%
Return on Capital
-116.79%
Return on Assets
-97.12%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$4.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
40.35M
Volume
1.82K
Avg. Volume
1.44K
Financials (TTM)
Gross Profit
-$4.67M
Operating Income
-$9.71M
EBITDA
-$4.50M
Operating Cash Flow
-$9.57M
Capital Expenditure
-$177.22K
Free Cash Flow
-$9.74M
Cash & ST Invst.
$137.42K
Total Debt
$19.64M
Nemaura Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
-$80.43K
-174939.1%
Gross Margin
0.00%
N/A
Market Cap
$4.00KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$111.11
N/A
Employees
36
N/A
Net Income
-$2.16M
-25.9%
EBITDA
-$155.37K
+71.1%
Quarterly Fundamentals
Total Cash
$137.42K
-98.1%
Total Debt
$19.64M
-2.1%
Accounts Receivable
$247.79K
+878.6%
Inventory
$3.67M
+56.1%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$19.64M
+70.6%
Return on Assets
-97.12%
N/A
Return on Invested Capital
1.25%
N/A
Free Cash Flow
-$1.49M
+6.8%
Operating Cash Flow
-$1.48M
+4.0%